VisalNumrungroadMD

Principal

Dr. Numrungroad is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Dr. Visal Numrungroad is a nephrologist in New Port Richey and Hudson, FL and is affiliated with multiple hospitals in the area, including Morton Plant North Bay Hospital, Medical Center of Trinity, and Regional Medical Center Bayonet Point. He received his medical degree from Universidad Central del Caribe School of Medicine and completed his residency and fellowship at University of South Florida College of Medicine. He and has been in practice 20 years. He also speaks multiple languages, including English, Spanish and Chinese (Mandarin). He is experienced in hypertension, electrolytes abnormalities, nephrotic/nephritic syndromes, kidney transplant management, continuous renal replacement therapy, peritoneal dialysis, hemodialysis, and renovascular disease. His interest in clinical research has led to many years of active involvement as Principal Investigator in many clinical trials associated with different bio-pharmaceutical companies.

Certificate of Appreciation for Volunteer Provider The Good Samaritan Health Clinic of Pasco, Inc. (Non-Profit), 2003-2022
Frist Humanitarian Physician Award HCA, 2018
CMS Meaningful Use Stage 1 Certification Practice Fusion EHR, Practice Fusion, Inc., 2012-2013

Journal Articles

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
George L. Bakris, M.D., Rajiv Agarwal, M.D., Stefan D. Anker, M.D., Ph.D., Bertram Pitt, M.D., Luis M. Ruilope, M.D., Peter Rossing, M.D., Peter Kolkhof, Ph.D., Christ..., NEJM, 12/3/2020
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J.L. Heerspink, Ph.D., Bergur V. Stefánsson, M.D., Ricardo Correa-Rotter, M.D., Glenn M. Chertow, M.D., Tom Greene, Ph.D., Fan-Fan Hou, M.D., Johannes F.E. Mann,..., NEJM, 10/8/2020
Effects of Selonsertib in Patients with Diabetic Kidney Disease
Glenn M. Chertow, Pablo E. Pergola, Fang Chen, Brian J. Kirby, John S. Sundy, Uptal D. Patel and for the GS-US-223-1015 Investigators, JASN, 10/30/2019

Other

A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes...
Eli Lilly
https://adisinsight.springer.com/trials/700219211
ClinicalTrials.gov Identifier: NCT01621178 - 7/24/2017

Medical Center of Trinity Recognizes Visal Numrungroad, MD, as its Frist Humanitarian Physician Award Winner for This YearSeptember 9th, 2020
PROJECT HOPE VOLUNTEERSSeptember 9th, 2020
Medical Center of Trinity honors staffSeptember 9th, 2020